Hypoxia-inducible factor: modern views

Xashimova G.T., Muhammadiev X.G, Valijonova M, Xidoyatova M.

dc.contributor.author	Xashimova G.T., Muhammadiev X.G, Valijonova M, Xidoyatova M.
dc.date.accessioned	2023-05-28T07:50:57Z
dc.date.available	2023-05-28T07:50:57Z
dc.date.issued	2023-04
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/8065
dc.description.abstract	Given its important function, the manipulation of HIF-1 activity in areas of ischemia and tumor masses has become a major focus of efforts to develop non- invasive, pharmaceutical treatment options for patients with cancer and heart disease. Although no such human protein has been successfully regulated by scientific methods, control of HIF-1 activity is becoming increasingly feasible as the details of its structure, function, and genetic pathway are elucidated.	en_US
dc.language.iso	en	en_US
dc.publisher	KLINIK LABORATOR DIAGNOSTIKADA INNOVATSION TEXNOLOGIYALARDAN FOYDALANISH, MUAMMOLAR VA YECHIMLAR	en_US
dc.relation.ispartofseries	№2;
dc.subject	hypoxia; ischemia; hypoxia-inducible factor; homeostasis; anaerobic glycolysis; Krebs cycle.	en_US
dc.title	Hypoxia-inducible factor: modern views	en_US
dc.type	Thesis	en_US